Content related to Single Cell, Sequencing and CyTOF (SC2) Core

Michael joined the Single Cell, Sequencing, and CyTOF (SC2) Core in 2018. In his role, he assists scientists in identifying and quantifying various biomarkers in tissue and liquid biopsy samples.

Researchers are searching for biomarkers to better identify which children with acute liver failure will recover on their own—and which will need a liver transplant.

New research aims to better diagnose, treat—and predict—liver transplant rejection in children.

CHLA core facilities share a common theme: The staff pride themselves on providing leading-edge technology, but they are also truly invested in the experiments and the scientists themselves.

Flow cytometry is a powerful tool to measure multiple biological characteristics of individual cells—analyzing millions of cells in a very short time. To assist investigators with this tool, the Flow

Open-source technique streamlines cell identification and analysis.

Children’s Hospital Los Angeles (CHLA) and Thermo Fisher Scientific have agreed to develop a next-generation sequencing (NGS)-based panel designed specifically for pediatric cancer research. The assay

The Biostatistics Core provides statistical support to researchers—fostering efficient and accurate data collection and analysis. The goal: enhance strong scientific processes and boost a project’s